세계 카프노그래피 장비 시장 규모는 2024-2031년 예측 기간 동안 6.75%의 CAGR로 2023년 4억 150만 달러에서 2031년 6억 7,706만 달러로 성장할 것으로 예상됩니다. 카프노그래피 장비 시장은 호흡기 질환의 유병률 증가, 비침습적 접근 방식에 대한 선호도 증가, 호흡기 치료법의 기술 발전, 의료 시설의 환자 대응 시설 확대 등 다양한 요인으로 인해 성장할 것으로 예측됩니다. 호흡기 질환을 앓고 있거나 인공호흡기 지원을 받고 있는 환자의 치료를 위해 카프노그래피 방법 및 장비의 채택이 증가함에 따라 카프노그래피 장비에 대한 수요가 크게 증가하고 있습니다.
전 세계 호흡기 질환의 급격한 증가로 인해 COVID-19 팬데믹 기간 동안 이러한 장비에 대한 수요가 크게 증가했습니다. 의료 분야에서 비침습적 방법에 대한 선호도가 높아짐에 따라 이러한 장비는 향후 주목할만한 견인력을 얻을 것으로 예상됩니다. 의료 전문가들은 환자 치료를 개선하기 위해 중환자실에 카프노그래피 기술을 도입했습니다. 또한 전염병으로 인한 원격 호흡 모니터링의 필요성으로 인해 그 사용이 증가하고 있습니다. 맥박 산소포화도 측정과 결합된 카프노그래피는 수술실에서 표준 모니터링 방법이 되었으며, 중등도 진정 및 진통과 같은 다른 환자 환경에서도 널리 사용되고 있습니다. 또한, 기관 내 삽관 시 기관 내 튜브 삽입을 확인하기 위해 모든 병원 환경에서 카프노그래피가 널리 사용되고 있습니다.
호흡기 감염, COPD, 천식, 폐암 등 호흡기 질환의 유병률 증가로 인해 카프노그래피 장비에 대한 수요가 크게 증가하고 있습니다. 카프노그래피 장비는 인공호흡기를 사용하는 환자를 모니터링하는 데 사용되는 호흡기 건강관리에 필수적인 도구입니다. 의료진이 호흡 튜브를 정확하게 장착하고 마취 시술을 할 때 도움이 됩니다. 천식이나 COPD와 같은 폐 질환 관리에도 중요한 역할을 하며, 환자의 호흡 기능을 실시간으로 모니터링하고 의료진에게 잠재적인 호흡 장애를 경고하는 등 WHO를 비롯한 여러 규제 기관에서 원격 비침습적 환자 모니터링에 필수적인 도구로 인정하고 있습니다. 필수적인 것으로 인정하고 있습니다. 호흡기 전염병(COVID-19)은 시장의 급격한 성장에 기여했습니다. 공해 및 기타 요인으로 인해 전 세계적으로 호흡기 질환의 유병률이 증가함에 따라 카프노그래피 장비에 대한 수요와 채택이 크게 증가할 것으로 예상됩니다.
이 보고서는 세계 카프노그래피 장비 시장을 조사하여 시장 개요와 함께 제품별, 기술별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.
Global capnography equipment market is projected to witness a CAGR of 6.75% during the forecast period 2024-2031F, growing from USD 401.5 million in 2023 to USD 677.06 million in 2031F. Capnography equipment market is anticipated to grow due to various factors such as the growing prevalence of respiratory disorders, growing preference for non-invasive approaches, technological advancements in respiratory treatment methods, and expansion of patient-compliant facilities in healthcare setups. The growing adoption of capnography methods and devices for the treatment of patients suffering from respiratory diseases or thriving on ventilation support has significantly expanded the demand for capnography equipment.
The demand for such devices was significantly boosted during the COVID-19 pandemic due to the sudden rise in respiratory conditions globally. With a growing preference for non-invasive methods in healthcare, these devices are anticipated to gain notable traction in the future. Healthcare professionals introduced capnography technology to intensive care units to improve patient care. Furthermore, its usage has increased due to the pandemic's need for remote respiratory monitoring. Capnography, combined with pulse oximetry, has become the standard monitoring practice in operating rooms and is gaining traction in other patient settings, such as moderate sedation and analgesia. Moreover, capnography is now widely used in all hospital settings to verify endotracheal tube placement during intubation.
For instance, the market gained traction from manufacturers and healthcare providers after the launch of the Global Capnography Project in 2016. The project aims to introduce capnography as a standard practice in healthcare settings to improve patient safety. Recent data from 2023 indicates that addressing the global capnography gap will enhance patient safety, with 90% of providers considering that capnography has saved lives.
Rising Prevalence of Respiratory Disorders
The rising prevalence of respiratory disorders, such as respiratory infections, COPD, asthma, and lung cancer, is significantly increasing the demand for capnography equipment. Capnography equipment are essential tool in respiratory healthcare used to monitor patients on ventilation supports. They help healthcare professionals accurately place breathing tubes and assist them through anesthetic procedures. These devices also play a crucial role in managing lung diseases, such as asthma and COPD, providing real-time monitoring of patient's respiratory function and alerting healthcare providers to potential breathing problems. WHO and other regulatory agencies have recognized these devices as crucial for remote and non-invasive patient monitoring. The respiratory pandemic, COVID-19, contributed to sudden growth in the market. The demand and adoption of capnography equipment are expected to increase significantly due to the rising prevalence of respiratory disease globally due to pollution and other factors.
For instance, in May 2023, according to the research published in BMC Anesthesiology, hypoxia in patients under observation was only a 5.4% incident in the capnography group compared with 14.2% in the standard group, proving the efficacy of capnography in reducing hypoxia and improving patient monitoring.
Technological Advances in Capnography
Recent advances in capnography technology have significantly improved patient monitoring in various healthcare settings, further boosting the market growth. These advancements include the introduction of micro-stream technology for side-stream sensors, main-stream sensors, ultra-compact MicroRotor technology, and the evolution of portable and compact capnometers. The real-time feedback mechanism of capnography devices significantly helps in growing its market share in respiratory medical devices. With the growing incidence of trauma and ICU cases, the target population is significantly increasing leading to higher demand for point-of-care and portable medical devices, further enhancing the market growth. Market players and regulatory agencies are constantly involved in the development of technically advanced capnography devices.
For instance, in March 2023, the United States FDA approved the CapnoSpot Pneumothorax Decompression Indicator manufactured by Pneumeric, Inc. which is a capnography equipment used for real-time monitoring of patients under decompressive thoracostomy. The device provides precision in the placement of needles and other medical devices during thoracic surgery by detecting the presence of carbon dioxide in the thoracic region.
Dominance of the Cardiac Care Segment
Cardiac care is the most common application of capnography devices. Capnography is used to monitor end-tidal carbon dioxide levels, which can indicate cardiac output and pulmonary blood flow. It is particularly useful during cardiopulmonary resuscitation (CPR) to assess the quality of chest compressions, confirm the correct placement of an endotracheal tube, and detect the onset of return of spontaneous circulation. Capnography is also used to guide decisions on the duration of CPR and to predict outcomes. With growing cardiac disease and obesity cases, the demand for capnography devices to treat cardiac conditions is anticipated to grow with time.
Hospitals are Chief End-users
Hospitals are the main end-users of capnography equipment, with a significant presence in the healthcare landscape. Studies indicate that nearly all hospitals in rural U.S., utilize continuous capnography for ventilated patients and often during procedural sedation. Hospitals require capnography facilities at their ICUs, which further affirms the lead of hospital segment. The high investment capacity of hospitals and permanent infrastructure make it more feasible for hospitals to procure and operate the capnography equipment. Usually, cardiac conditions, respiratory disorders, and trauma cases are treated by hospitals, which further enhances the demand for capnography equipment.
North America to be the Dominating Region
Capnography devices are more common in North America compared to other regions due to their significant impact on patient safety and outcomes. North America is expected to gain the largest share of the global capnography equipment market due to the increasing number of surgeries and the widespread use of capnography devices by medical professionals in the U.S. and Canada. In North America, respiratory diseases are widespread, driving up the need for capnography devices in healthcare facilities. The region's robust healthcare system and emphasis on patient safety have fostered the adoption of innovative medical technologies such as capnography. In addition, the region boasts a significant number of hospitals and surgical centers, which are the primary consumers of these devices. The presence of industry leaders such as Becton Dickinson, Philips, Masimo, Medtronic, and others has also thrived market growth in North America.
Future Market Scenario (2024-2031F)
The adoption of capnography devices in low-income countries is indeed considered the future of capnography. Studies have shown that the implementation of capnography in low-income countries such as Malawi has had a significant impact on patient safety, with anesthesia providers reporting that capnography helped prevent complications and saved lives. The Global Capnography Project (GCAP) in Malawi demonstrated that capnography is an essential monitor for safe anesthesia care and can improve the early recognition of critical airway incidents. The success of projects such as GCAP highlights the importance of making capnography more widely available globally to enhance patient safety. Efforts are being made to close the global capnography gap, with calls for urgent action to improve patient safety by increasing access to capnography in low- and middle-income countries. Initiatives are being proposed to address this gap, such as building coalitions, setting standards, securing funding, developing training tools, and manufacturing low-cost capnography units to facilitate broader use of capnography globally.
For instance, in September 2023, the Anesthesia Department at Mulago Hospital in Uganda, East Africa procured and installed a new capnography device to enhance their anesthesia facilities and address the shortage of anesthesiologists in the country. The device is anticipated to help the professionals in positioning tubes for monitoring patients' respiration during surgery.
Key Players Landscape and Outlook
These companies play a crucial role in the development and distribution of capnography equipment globally, catering to various healthcare sectors such as cardiology, emergency care, and others. The market has not witnessed any notable market tactics in recent times other than the last significant acquisition of Smiths Medicals in the year 2022. In January 2022, ICU Medical acquired Smiths Medical from Smiths Group. Smith Medical specializes in syringes, infusion devices, vascular access, and life-support products. This acquisition combines these offerings with ICU Medical's existing products, resulting in a significant player in infusion therapy with a projected annual revenue of about USD 2.5 billion. Through this acquisition, the capnography portfolio of Smith Medical goes to ICU Medical's offerings.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.